tPCS as a method for correcting cardiac arrhythmias after percutaneous transluminal coronary angioplasty with stenting in patients with myocardial infarction
Open Access
- 21 September 2022
- journal article
- research article
- Published by Scientific Research Institute - Ochapovsky Regional Clinical Hospital No 1 in Innovative Medicine of Kuban
- No. 3,p. 29-36
Abstract
Objective: To study the effect of transcranial pulsed current stimulation (tPCS) therapy on cardiac arrhythmias developed after percutaneous transluminal coronary angioplasty (PTCA) with stenting in patients with myocardial infarction (MI).Material and methods: Characteristics of patient groups: the comparison group (n = 17) – with myocardial infarction, after PTCA with stenting, standard treatment; the main group (n = 21) – the same and tPCS therapy. Control points of the study: 1st day – Electrocardiography (ECG), Echocardiography (ECHO), Creatine phosphokinase (CPK), Creatine phosphokinase-MB (CPK-MB), Troponin-I, potassium, β-endorphin; 5th day – the same without ECHO; 10th day – the same and ECG with the determination of harmony and quantum of the electromagnetic flux of the cardiac cycle. PTCA was performed using drug-eluting stents. tPCS therapy was performed in pulsed bipolar mode, current strength 2 mA, current frequency 77.5 Hz, session duration 45 min.Results: In patients of the main group (against the background of tPCS therapy), the studied parameters of the cardiac cycle approached the optimal values. It was shown that intergroup differences in harmony (p = 0.002) and the size of the electromagnetic flux quantum of the cardiac cycle (p = 0.001) are statistically significant. Also, against the background of the tPCS therapy, the concentration of highly sensitive troponin-I is statistically significantly (p = 0.0042) lower by 109%. On the 5th and 10th days of the study, the serum concentration of β-endorphin in the main group was higher by 38.3 and 35.0% than in the comparison group (p < 0.05).Conclusion: The results of the study clearly demonstrate the cardioprotective and antiarrhythmic potential of tPCS therapy in patients with myocardial infarction and cardiac arrhythmias after PTCA with stenting.Keywords
This publication has 11 references indexed in Scilit:
- Incidence of atrial fibrillation and its effects on long-term follow-up outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarctionThe Anatolian Journal of Cardiology, 2021
- Percutaneous management of reperfusion arrhythmias during primary percutaneous coronary intervention: a case reportThe Egyptian Heart Journal, 2021
- Stress-Induced Myocardial Damage and Antiarrhythmic Effect of Opioid PeptidesКардиология в Беларуси, 2021
- Intra-procedural arrhythmia during cardiac catheterization: A systematic review of literatureWorld Journal of Cardiology, 2020
- 2018 ESC/EACTS guidelines on myocardial revascularizationRussian Journal of Cardiology, 2019
- THE COMBINED USE OF TRANSCRANIAL ELECTRO-STIMULATION IN REHABILITATION AND SPORTS MEDICINEClinical Medicine and Pharmacology, 2019
- Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in HumansCirculation, 2016
- Cardiac Oxidative Stress and Inflammatory Cytokines Response after Myocardial InfarctionCurrent Vascular Pharmacology, 2015
- Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxiaLife Sciences, 2013
- A comparison of electrocardiographic changes during reperfusion of acute myocardial infarction by thrombolysis or percutaneous transluminal coronary angioplastyAmerican Heart Journal, 2000